Related Experiment Video
Updated: Apr 11, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Idiopathic disseminated bacillus Calmette-Guerin infection in three infants
Jun Kido1,2, Tomoyuki Mizukami3,4, Osamu Ohara5
1Department of Pediatrics, Kumamoto Regional Medical Center, Kumamoto, Chiba, Japan.
Insights
Disseminated bacillus Calmette-Guerin (BCG) infection can occur in healthy infants after vaccination. Caution is advised when administering BCG vaccines to young infants due to their immature immune systems.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Bacillus Calmette-Guerin (BCG) vaccination is a common preventive measure against tuberculosis.
- Disseminated BCG infection is a rare but serious adverse event, typically associated with underlying immunodeficiency.
Observation:
- Three healthy infants aged 4-9 months developed disseminated BCG infection post-vaccination.
- Symptoms included persistent fever, skin rash, and multiple chest nodules detected via CT scan 22-34 days after BCG inoculation.
- Immunological profiles of affected infants, including T cell and neutrophil levels, were within normal ranges.
Findings:
- Disseminated BCG infection can occur in infants with normal immune function.
- Immature immune systems in early infants may increase susceptibility to disseminated BCG infection, even without pre-existing immune abnormalities.
- Computed tomography is effective in identifying disseminated BCG infection manifestations.
Implications:
- Healthcare providers should exercise caution when administering BCG vaccines to early infants.
- Further research may be needed to understand the specific immunological factors contributing to disseminated BCG infection in immunocompetent infants.
- Early recognition and management are crucial for infants presenting with symptoms suggestive of disseminated BCG infection post-vaccination.
Abstract:
We describe the cases of three infants between 4 and 9 months of age with disseminated bacillus Calmette-Guerin (BCG) infection who developed persistent fever, skin rash, and multiple chest nodules visible on computed tomography 22-34 days after BCG vaccination. These infants were healthy before inoculation, and their detailed immunological profiles, including T cell and neutrophil levels, were within normal range. Most reported BCG cases involve impaired immunity, such as children with chronic granulomatous disease, severe combined immunodeficiency, or human immunodeficiency virus infections. Because of their immature immune systems, BCG vaccination can be hazardous even in early infants without immune abnormalities. Hence, we advise caution when administering BCG vaccines to early infants.
More Related Videos
10:11Expression of Exogenous Antigens in the Mycobacterium bovis BCG Vaccine via Non-genetic Surface Decoration with the Avidin-biotin System
Published on: January 31, 2018
07:14A CFSE-based Assay to Study the Migration of Murine Skin Dendritic Cells into Draining Lymph Nodes During Infection with Mycobacterium bovis Bacille Calmette-Guérin
Published on: October 9, 2016
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cytomegalovirus Disease
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...